Tenaya Therapeutics (TNYA) Other financing activities (2021 - 2026)

Tenaya Therapeutics' quarterly Other financing activities came in at $415000.0 in Q1 2026, down 87.18% quarter-over-quarter from $3.2 million in Q4 2024.

Tenaya Therapeutics has reported Other financing activities for 4 years, with the latest figure at $415000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $415000.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (changed N/A YoY), and the FY2024 full-year result was $3.2 million, up 545.91% from the prior year.
  • Other financing activities for Q1 2026 stood at $415000.0, down from $3.2 million in the prior quarter.
  • The five-year high for Other financing activities was $3.2 million in Q1 2024, with the low at -$3.2 million in Q2 2024.
  • Average Other financing activities over 3 years is $712000.0, with a median of $458000.0 recorded in 2023.
  • Peak annual rise in Other financing activities reached 545.91% in 2024, while the deepest fall reached 2796.67% in 2024.
  • Tracing TNYA's Other financing activities over 3 years: stood at $120000.0 in 2023, then surged by 2596.67% to $3.2 million in 2024, then slumped by 87.18% to $415000.0 in 2026.
  • The last three Other financing activities figures came in at $415000.0 (Q1 2026), $3.2 million (Q4 2024), and -$3.2 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Tenaya Therapeutics 193.57 Mn 193.57 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 415,000.00
Mar 31, 2026 415,000.00
Dec 31, 2024 3.24 Mn
Dec 31, 2024 3.24 Mn
Jun 30, 2024 -3.24 Mn
Jun 30, 2024 -3.24 Mn
Mar 31, 2024 3.24 Mn
Mar 31, 2024 3.24 Mn
Jun 30, 2023 120,000.00
Jun 30, 2023 120,000.00
Mar 31, 2023 501,000.00
Mar 31, 2023 501,000.00
Sep 30, 2021 18.46 Mn
Sep 30, 2021 18.46 Mn
Jun 30, 2021 1.37 Mn
Jun 30, 2021 1.37 Mn
Mar 31, 2021 20,000.00
Mar 31, 2021 20,000.00